Endothelial dysfunction and renal fibrosis in endotoxemia-induced oliguric kidney injury: possible role of LPS-binding protein

Abstract

IntroductionThe pathophysiology of endotoxemia-induced acute kidney injury (AKI) is characterized by an intense activation of the host immune system and renal resident cells by lipopolysaccharide (LPS) and derived proinflammatory products. However, the occurrence of renal fibrosis in this setting has been poorly investigated. The aim of the present study was to investigate the possible association between endothelial dysfunction and acute development of tissue fibrosis in a swine model of LPS-induced AKI. Moreover, we studied the possible effects of coupled plasma filtration adsorption (CPFA) in this setting.MethodsAfter 9 hours from LPS infusion and 6 hours of CPFA treatment, histologic and biochemical changes were analyzed in pigs. Apoptosis and endothelial dysfunction were assessed on renal biopsies. The levels of LPS-binding protein (LBP) were quantified with enzyme-linked immunosorbent assay (ELISA). Endothelial cells (ECs) were stimulated in vitro with LPS and cultured in the presence of swine sera and were analyzed with FACS and real-time RT-PCR.ResultsIn a swine model of LPS-induced AKI, we observed that acute tubulointerstitial fibrosis occurred within 9 hours from LPS injection. Acute fibrosis was associated with dysfunctional alpha-smooth muscle actin (α-SMA)+ ECs characterized by active proliferation (Ki-67+) without apoptosis (caspase-3-). LPS led to EC dysfunction in vitro with significant vimentin and N-cadherin expression and increased collagen I mRNA synthesis. Therapeutic intervention by citrate-based CPFA significantly prevented acute fibrosis in endotoxemic animals, by preserving the EC phenotype in both peritubular capillaries and renal arteries. We found that the removal of LBP from plasma was crucial to eliminate the effects of LPS on EC dysfunction, by blocking LPS-induced collagen I production.ConclusionsOur data indicate that EC dysfunction might be pivotal in the acute development of tubulointerstitial fibrosis in LPS-induced AKI. Selective removal of the LPS adaptor protein LBP might represent a future therapeutic option to prevent EC dysfunction and tissue fibrosis in endotoxemia-induced AKI.

Renal progenitor cells revert LPS‐induced endothelial‐to‐mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides

“…The induction of sepsis was performed in all groups using 300 mg/kg of LPS membrane of Escherichia coli diluted in 10 ml of saline solution as previously described by us (3). The LPS injection was administered ;15 min after the stabilization of the anesthetic plan and infused over 30 min.…”

Endothelial dysfunction and mechanobiology in pathological cutaneous scarring: lessons learned from soft tissue fibrosis

“…In pigs with endotoxaemia‐induced oliguric kidney injury, there is a strong correlation between endotoxaemia‐induced EDs and the development of acute renal fibrosis. Significantly, the dysfunctional ECs acquire myofibroblast markers such as α‐smooth muscle actin (SMA) and produce collagen I . This phenomenon, which is termed endothelial‐to‐mesenchymal transition (EndoMT), produces up to 10% of the myofibroblasts in kidney fibrosis.…”

Toll-like receptor-9 is involved in the development of B cell stimulating factor-induced systemic lupus erythematosus

“…Lipopolysaccharide (LPS) from the wall of Gram-negative bacteria is the main ligand of TLR-9 (27). Additionally, TLR-9, CD14, myeloid differentiation protein 2 and LPS binding protein combine to form the LPS recognition receptor complex, with a high affinity and signal transduction function (28). The LPS recognition receptor may cause the translocation of nuclear factor-κB (NF-κB) from the cytoplasm to the nucleus by myeloid differentiation protein 88 (MyD88)-dependent or independent signaling pathways and bind with the NF-site in the promoter region of inflammatory response regulator genes, promoting the initiation of transcription and translation of genes encoding inflammatory cytokines, as well as the large release of cytokines (29).…”